Conjugates and compositions for cellular delivery
This invention features conjugates, degradable linkers, compositions, methods of synthesis, and applications thereof, including cholesterol derived conjugates of biologically active compounds, including antibodies, antivirals, chemotherapeutics, peptides, proteins, hormones, nucleosides, nucleotides, non-nucleosides, and nucleic acids including enzymatic nucleic acids, DNAzymes, allozymes, antisense, dsRNA, siNA, siRNA, triplex oligonucleotides, 2,5-A chimeras, decoys and aptamers.
1. A compound having Formula 107:
wherein X comprises a short interfering RNA (siRNA) comprising 2′-fluoro pyrimidines and 2′-O-methyl purines; each W independently comprises a linker molecule selected from the group consisting of amide, phosphate, phosphate ester, phosphoramidate, thiophosphate ester linkage, and R 3 (CH 2 ) 2 O(CH 2 ) 2 (OCH 2 CH 2 ) n O(CH 2 ) 2 NHC(=0)—, where n is independently an integer from about 1 to about 20; Y comprises a linker molecule that can be present or absent; each R1, R2, R3, and R4 independently comprises O, OH, H, alkyl, alkylhalo, O-alkyl, O-alkylcyano, S, S-alkyl, S-alkylcyano, or N; and Cholesterol comprises cholesterol.
2. The compound of claim 1 , wherein said W-Cholesterol comprises a compound having Formula 109:
wherein n is independently an integer from about 1 to about 20.
3. The compound of claim 1 , wherein said siRNA molecule comprises a sense strand and an antisense strand, and wherein said sense strand is conjugated with a compound comprising Formula 107.